You have to think more like Mero. Ignore that they have a growing pipeline, ignore they have $125M in cash. Ignore that they are about to see a $5M milestone + another $5M milestone once Dacogen see's $100M in sales for aml. Ignore that 4 drugs will have data at ash.
Ignore the possible $30M in increasing revenues that we could start seeing some as soon as the 1Q13. BTW all of the 4Q revenues will be at the 30% figure. JNJ probably already has boots on the ground. It sounds like mero missed a buying opportunity and given that his good pal rory, bragged about selling 1/2 his position at 2.30 range.
As this increases in value, rory and mero have to decided to they chase it or talk it down. They fail to realize, they have neither the wit nor the clout to move this either way. They just watching as this the bus pulls away.
I have more shares than you could ever dream of having.
Biotech investing is hard at best. For every drug approved 100's fail. Billions of dollars lost. Astex has a potential in s110. But It took 5 years to get to phase 1 and most likely another 5 years to get approved if luckly. I have the funds to gamble and I am willing to hold.
Okay J Paul Getty. First of all, I don't care, second you have no idea of how many shares anyone has to make these claims.
I just wonder, why would you invest in a company that you despise the CEO. Specially shares we only could only dream about.
No, what you're willing to do is whine. The glass is always half empty with you mero. As for potential of sgi-110, that 5 years is now down to 2 years. I believe they have a shot at approval after ph2 for MDS. Slim, but not impossible.
Looks like the man with greatest investment in ASTX, doesn't even have a sentiment disclosure. Must be that stack of shares he has is blocking the button. I love how the dingdongs always want to paint them selfs as major players. I think you and rory toy around in make believe word to much.